Loading
Latest filing published 30 Jul 2026 for Aytu Biopharma, INC. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Carl Dockery appears in our data through filings on Aytu Biopharma, Inc shares, published by SEC (Form 4). We count 5 filings; the first trade dates from 21 December 2022 and the latest from 28 July 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The latest filing, published on 30 July 2026, reports a share grant in Aytu Biopharma, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations